This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Turner, J.
Right arrow Articles by Orme, I. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Turner, J.
Right arrow Articles by Orme, I. M.

 Previous Article  |  Next Article 

Infection and Immunity, March 2000, p. 1706-1709, Vol. 68, No. 3
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Effective Preexposure Tuberculosis Vaccines Fail To Protect When They Are Given in an Immunotherapeutic Mode

Joanne Turner,1 Elizabeth R. Rhoades,1 Marc Keen,1 John T. Belisle,1 Anthony A. Frank,2 and Ian M. Orme1,*

Mycobacteria Research Laboratories, Departments of Microbiology1 and Pathology,2 Colorado State University, Fort Collins, Colorado 80523

Received 27 September 1999/Returned for modification 3 November 1999/Accepted 19 November 1999

Two vaccine formulations previously shown to induce protective immunity in mice and prevention of long-term necrosis in guinea pigs were tested as potential immunotherapeutic vaccines in mice earlier infected by aerosol with Mycobacterium tuberculosis. Neither vaccine had any effect on the course of the infection in the lungs, but both reduced the bacterial load in the spleen. Similarly, inoculation with Mycobacterium bovis BCG had no effect whatsoever and, if given more than once, appeared to induce an increasingly severe pyogranulomatous response in the lungs of these mice.


* Corresponding author. Mailing address: Department of Microbiology, Colorado State University, Fort Collins, CO 80523. Phone: (970) 491-5777. Fax: (970) 491-5125. E-mail: iorme{at}lamar.colostate.edu.


Infection and Immunity, March 2000, p. 1706-1709, Vol. 68, No. 3
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Guirado, E., Gil, O., Caceres, N., Singh, M., Vilaplana, C., Cardona, P.-J. (2008). Induction of a Specific Strong Polyantigenic Cellular Immune Response after Short-Term Chemotherapy Controls Bacillary Reactivation in Murine and Guinea Pig Experimental Models of Tuberculosis. CVI 15: 1229-1237 [Abstract] [Full Text]  
  • Doherty, T. M., Andersen, P. (2005). Vaccines for Tuberculosis: Novel Concepts and Recent Progress. Clin. Microbiol. Rev. 18: 687-702 [Abstract] [Full Text]  
  • Dheda, K., Chang, J.-S., Breen, R. A. M., Kim, L. U., Haddock, J. A., Huggett, J. F., Johnson, M. A., Rook, G. A. W., Zumla, A. (2005). In Vivo and In Vitro Studies of a Novel Cytokine, Interleukin 4{delta}2, in Pulmonary Tuberculosis. Am. J. Respir. Crit. Care Med. 172: 501-508 [Abstract] [Full Text]  
  • Copenhaver, R. H., Sepulveda, E., Armitige, L. Y., Actor, J. K., Wanger, A., Norris, S. J., Hunter, R. L., Jagannath, C. (2004). A Mutant of Mycobacterium tuberculosis H37Rv That Lacks Expression of Antigen 85A Is Attenuated in Mice but Retains Vaccinogenic Potential. Infect. Immun. 72: 7084-7095 [Abstract] [Full Text]  
  • Sampson, S. L., Dascher, C. C., Sambandamurthy, V. K., Russell, R. G., Jacobs, W. R. Jr., Bloom, B. R., Hondalus, M. K. (2004). Protection Elicited by a Double Leucine and Pantothenate Auxotroph of Mycobacterium tuberculosis in Guinea Pigs. Infect. Immun. 72: 3031-3037 [Abstract] [Full Text]  
  • Buddle, B. M., Wedlock, D. N., Parlane, N. A., Corner, L. A. L., de Lisle, G. W., Skinner, M. A. (2003). Revaccination of Neonatal Calves with Mycobacterium bovis BCG Reduces the Level of Protection against Bovine Tuberculosis Induced by a Single Vaccination. Infect. Immun. 71: 6411-6419 [Abstract] [Full Text]  
  • Huygen, K. (2003). On the Use of DNA Vaccines for the Prophylaxis of Mycobacterial Diseases. Infect. Immun. 71: 1613-1621 [Full Text]  
  • Taylor, J. L., Turner, O. C., Basaraba, R. J., Belisle, J. T., Huygen, K., Orme, I. M. (2003). Pulmonary Necrosis Resulting from DNA Vaccination against Tuberculosis. Infect. Immun. 71: 2192-2198 [Abstract] [Full Text]  
  • Repique, C. J., Li, A., Collins, F. M., Morris, S. L. (2002). DNA Immunization in a Mouse Model of Latent Tuberculosis: Effect of DNA Vaccination on Reactivation of Disease and on Reinfection with a Secondary Challenge. Infect. Immun. 70: 3318-3323 [Abstract] [Full Text]  
  • Moreira, A. L., Tsenova, L., Haile Aman, M., Bekker, L.-G., Freeman, S., Mangaliso, B., Schroder, U., Jagirdar, J., Rom, W. N., Tovey, M. G., Freedman, V. H., Kaplan, G. (2002). Mycobacterial Antigens Exacerbate Disease Manifestations in Mycobacterium tuberculosis-Infected Mice. Infect. Immun. 70: 2100-2107 [Abstract] [Full Text]  
  • Tanghe, A., Content, J., Van Vooren, J.-P., Portaels, F., Huygen, K. (2001). Protective Efficacy of a DNA Vaccine Encoding Antigen 85A from Mycobacterium bovis BCG against Buruli Ulcer. Infect. Immun. 69: 5403-5411 [Abstract] [Full Text]  
  • Orme, I. M. (2001). The search for new vaccines against tuberculosis. J. Leukoc. Biol. 70: 1-10 [Abstract] [Full Text]  
  • Rook, G.A.W., Seah, G., Ustianowski, A. (2001). M. tuberculosis: immunology and vaccination. Eur Respir J 17: 537-557 [Abstract] [Full Text]  
  • Turner, O. C., Roberts, A. D., Frank, A. A., Phalen, S. W., McMurray, D. M., Content, J., Denis, O., D'Souza, S., Tanghe, A., Huygen, K., Orme, I. M. (2000). Lack of Protection in Mice and Necrotizing Bronchointerstitial Pneumonia with Bronchiolitis in Guinea Pigs Immunized with Vaccines Directed against the hsp60 Molecule of Mycobacterium tuberculosis. Infect. Immun. 68: 3674-3679 [Abstract] [Full Text]